Release date: 2024-08-28 16:35:18 Article From: Lucius Laos Recommended: 141
Stiripentol is an innovative antiepileptic drug used to treat Dravet syndrome, mainly by enhancing GABAergic nerve conduction and reducing the frequency of seizures in patients. In 2018, it was approved by the United States FDA for use, which significantly improved the quality of life of patients.
Stiripentol is currently available in several versions, including:
250 mg*60 packs, the price of each box is about 3300 yuan; 500 mg*60 packets, each box is about 6000 yuan.
250 mg*60 capsules, about 2800 yuan per box; 500 mg*60 capsules, about 4500 yuan per box.
Depending on the patient's needs, different dosage forms and specifications of Stiripentol can be selected for treatment. Patients should also know who the drug is for before purchasing it.
Patients who meet the indications for the drug may achieve better efficacy with the drug.
Stipentol is indicated for the treatment of seizures associated with Dravet syndrome (DS) in patients who have taken clobazam and are over 6 months of age and weigh at least 7 kg. There are currently no clinical data to support the use of Stiripentol alone in the treatment of Dravet syndrome.
In addition to knowing who the drug is for, patients should also know how to use the drug before taking it as prescribed.
According to the drug instructions, the general recommended dosage requirements of drugs are sorted out as follows:
Before the first use of stitapentol, it is recommended to have a blood test to understand the basic health of the patient.
The recommended oral dose of stidipentol is 50 mg/kg per day in 2 or 3 divided doses, depending on the patient's age and weight.
If the exact dose cannot be calculated, the dose can be rounded to the nearest range, usually between 50 mg and 150 mg. Precise dosing can be achieved by combining drugs of different strengths. The maximum recommended daily dose is 3,000 mg.
Patients should follow their doctor's individualized medication recommendations and take their medications on time and in the right amount.
[Warm tips] The use of stipentol needs to be carried out under the guidance of a doctor. Patients should pay attention to the changes in their condition during the medication and communicate with the doctor in time to avoid adverse reactions.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: